Who is sponsoring NCT03960424?

NCT03960424 is sponsored by Northwell Health.

What drugs are being tested in NCT03960424?

Interventions in NCT03960424: Comprehensive Outpatient Management, Diabetes Telemonitoring.

What condition does NCT03960424 study?

NCT03960424 studies Type 2 Diabetes Mellitus, Type 2 Diabetes.

Is NCT03960424 still recruiting?

NCT03960424 is currently completed. Last updated 16 October 2023.

Last reviewed 2023-10-16 · How we verify

NCT03960424

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diabetes Management Program for Hispanic/Latino

Completed NA Last updated 16 October 2023

What this trial tests

NA trial testing Comprehensive Outpatient Management in Type 2 Diabetes Mellitus in 240 participants. Completed in 8 September 2023.

Timeline

30 September 2019

Primary endpoint
12 March 2023

8 September 2023

Quick facts

Lead sponsor	Northwell Health
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	sequential
Masking	none
Primary purpose	treatment
Enrollment	240
Start date	30 September 2019
Primary completion	12 March 2023
Estimated completion	8 September 2023
Sites	1 location across United States

Drugs / interventions tested

Comprehensive Outpatient Management
Diabetes Telemonitoring

Conditions studied

Type 2 Diabetes Mellitus — all drugs for Type 2 Diabetes Mellitus →
Type 2 Diabetes — all drugs for Type 2 Diabetes →

Sponsor

Northwell Health — full company profile →

Who can join

18 and older, any sex, with Type 2 Diabetes Mellitus or Type 2 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare Diabetes Telemonitoring to comprehensive outpatient management (COM) on critical patient-centered outcomes, including HbA1c.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Interventions for improving health literacy in migrants.
Baumeister A, Aldin A, Chakraverty D, Hübner C, et al · · 2023 · cited 22× · PMID 37963101 · DOI 10.1002/14651858.cd013303.pub2
Adapting a home telemonitoring intervention for underserved Hispanic/Latino patients with type 2 diabetes: an acceptability and feasibility study.
Pekmezaris R, Williams MS, Pascarelli B, Finuf KD, et al · · 2020 · cited 20× · PMID 33287815 · DOI 10.1186/s12911-020-01346-0
COVID-19 stressors for Hispanic/Latino patients living with type 2 diabetes: a qualitative study.
Williams MS, Cigaran E, Martinez S, Marino J, et al · · 2023 · cited 4× · PMID 37187937 · DOI 10.3389/fcdhc.2023.1070547
Ensuring fidelity: key elements to consider in disseminating a diabetes telemanagement program for underserved Hispanic/Latinos living with type 2 diabetes.
Martinez S, Nouryan CN, Williams MS, Patel VH, et al · · 2024 · PMID 38436046 · DOI 10.3389/fcdhc.2024.1328993

Verify or expand the search:

Other recruiting trials for Type 2 Diabetes Mellitus

Currently open trials in the same condition.

NCT07351058 — A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight and Type 2 Diabetes · Phase 3 · recruiting
NCT07373938 — Carotid Wall Texture as a Cardiovascular Risk Biomarker in Type 2 Diabetes Mellitus · recruiting
NCT07433062 — A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With · Phase 1 · recruiting
NCT07276776 — An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes · NA · active not recruiting
NCT07232537 — An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic · recruiting

Other Northwell Health trials

Trials by the same sponsor.

NCT07253662 — Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients With Peritoneal Metastasis From Pancreatic Aden · Phase 1 · recruiting
NCT07191041 — Emotional Urinary Tract Infection · not yet recruiting
NCT07254091 — Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer · EARLY_PHASE1 · recruiting
NCT07344961 — Determinates of Atrial Tracking and Prevalence of Atrial Fibrillation in the Micra AV2 (DANCE AFIB) · recruiting
NCT07193862 — Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Meta · EARLY_PHASE1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03960424 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Northwell Health
Last refreshed: 16 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03960424.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing